Skip to menu Skip to content Skip to footer
Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Overview

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Works

Search Professor Dan Siskind’s works on UQ eSpace

376 works between 2007 and 2025

121 - 140 of 376 works

2021

Journal Article

Tardive seizures after electroconvulsive therapy

Warren, Nicola, Eyre-Watt, Brenton, Pearson, Ella, O'Gorman, Cullen, Watson, Emily, Lie, David and Siskind, Dan (2021). Tardive seizures after electroconvulsive therapy. The Journal of ECT, 38 (2), 95-102. doi: 10.1097/yct.0000000000000821

Tardive seizures after electroconvulsive therapy

2021

Journal Article

Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls

Suetani, Shuichi, Honarparvar, Faraz, Siskind, Dan, Hindley, Guy, Veronese, Nicola, Vancampfort, Davy, Allen, Lauren, Solmi, Marco, Lally, John, Gaughran, Fiona, Stubbs, Brendon and Pillinger, Toby (2021). Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls. Schizophrenia Research, 237, 131-140. doi: 10.1016/j.schres.2021.08.022

Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls

2021

Journal Article

Clozapine levels as a predictor for therapeutic response: a systematic review and meta‐analysis

Siskind, Dan, Sharma, Meghna, Pawar, Mrinal, Pearson, Ella, Wagner, Elias, Warren, Nicola and Kisely, Steve (2021). Clozapine levels as a predictor for therapeutic response: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica, 144 (5), 422-432. doi: 10.1111/acps.13361

Clozapine levels as a predictor for therapeutic response: a systematic review and meta‐analysis

2021

Journal Article

CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

Siskind, Dan, Russell, Anthony W., Suetani, Shuichi, Flaws, Dylan, Kisely, Steve, Moudgil, Vikas, Northwood, Korinne, Robinson, Gail, Scott, James G., Stedman, Terry, Warren, Nicola, Winckel, Karl, Cosgrove, Peter and Baker, Andrea (2021). CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine. Therapeutic Advances in Psychopharmacology, 11 204512532110452, 1-12. doi: 10.1177/20451253211045248

CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine

2021

Journal Article

Excess mortality from cancer in people with mental illness—Out of sight and out of mind

Kisely, Stephen and Siskind, Dan (2021). Excess mortality from cancer in people with mental illness—Out of sight and out of mind. Acta Psychiatrica Scandinavica, 144 (4), 315-317. doi: 10.1111/acps.13363

Excess mortality from cancer in people with mental illness—Out of sight and out of mind

2021

Journal Article

Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review

Wagner, Elias, Siafis, Spyridon, Fernando, Piyumi, Falkai, Peter, Honer, William G., Röh, Astrid, Siskind, Dan, Leucht, Stefan and Hasan, Alkomiet (2021). Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review. Translational Psychiatry, 11 (1) 487, 1-18. doi: 10.1038/s41398-021-01613-2

Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review

2021

Journal Article

Prevalence of dental disorders among people with mental illness: an umbrella review

Choi, Jisu, Price, Josh, Ryder, Samuel, Siskind, Dan, Solmi, Marco and Kisely, Steve (2021). Prevalence of dental disorders among people with mental illness: an umbrella review. Australian and New Zealand Journal of Psychiatry, 56 (8), 48674211042239-963. doi: 10.1177/00048674211042239

Prevalence of dental disorders among people with mental illness: an umbrella review

2021

Journal Article

Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis

Stogios, Nicolette, Smith, Emily, Bowden, Sylvie, Tran, Veronica, Asgariroozbehani, Roshanak, McIntyre, William Brett, Remington, Gary, Siskind, Dan, Agarwal, Sri Mahavir and Hahn, Margaret K. (2021). Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis. Neuropsychopharmacology, 47 (3), 664-672. doi: 10.1038/s41386-021-01163-7

Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis

2021

Journal Article

An assessment of psychological distress and professional burnout in mental health professionals in Australia during the COVID-19 pandemic

Northwood, K., Siskind, D., Suetani, S. and McArdle, P.A. (2021). An assessment of psychological distress and professional burnout in mental health professionals in Australia during the COVID-19 pandemic. Australasian Psychiatry, 29 (6), 628-634. doi: 10.1177/10398562211038906

An assessment of psychological distress and professional burnout in mental health professionals in Australia during the COVID-19 pandemic

2021

Conference Publication

Thermosensitive Micellar Hydrogels of Clozapine for Nose-to-Brain Delivery

Tan, Madeleine SA, Pandey, Preeti, Balmanno, Alexandra, Falconer, James R., Siskind, Dan J. and Parekh, Harendra S. (2021). Thermosensitive Micellar Hydrogels of Clozapine for Nose-to-Brain Delivery. 2021 CRS Virtual Annual Meeting, Mount Laurel, NJ United States, 25-29 July 2021 .

Thermosensitive Micellar Hydrogels of Clozapine for Nose-to-Brain Delivery

2021

Journal Article

Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential

Flintoff, Jonathan, Kesby, James P., Siskind, Dan and Burne, Thomas H. J. (2021). Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential. Expert Opinion on Investigational Drugs, 30 (8), 877-891. doi: 10.1080/13543784.2021.1951702

Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential

2021

Journal Article

Colorectal cancer outcomes in people with severe mental illness cohort (COSMIC): a protocol for an Australian retrospective cohort using linked administrative data

Protani, Melinda M., Jordan, Susan J., Kendall, Bradley J., Siskind, Dan, Lawrence, David, Sara, Grant, Brophy, Lisa and Kisely, Steve (2021). Colorectal cancer outcomes in people with severe mental illness cohort (COSMIC): a protocol for an Australian retrospective cohort using linked administrative data. BMJ Open, 11 (6) 044737, e044737. doi: 10.1136/bmjopen-2020-044737

Colorectal cancer outcomes in people with severe mental illness cohort (COSMIC): a protocol for an Australian retrospective cohort using linked administrative data

2021

Conference Publication

Inaccurate QT interval estimation in people taking antipsychotics: are we contributing to misinformed treatment decisions?

Andric, T., Winckel, K., Tanzer, T., Siskind, D., Hollingworth, S., Smith, L. and Isoardi, K. (2021). Inaccurate QT interval estimation in people taking antipsychotics: are we contributing to misinformed treatment decisions?. National Medicines Symposium, Online, 18 May 2021.

Inaccurate QT interval estimation in people taking antipsychotics: are we contributing to misinformed treatment decisions?

2021

Journal Article

Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis

Siskind, Dan, Orr, Stacy, Sinha, Surabhi, Yu, Ou, Brijball, Bhavna, Warren, Nicola, MacCabe, James H., Smart, Sophie E. and Kisely, Steve (2021). Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis. The British Journal of Psychiatry, 220 (3) PII S0007125021000611, 1-6. doi: 10.1192/bjp.2021.61

Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis

2021

Journal Article

Bazett's correction formula overestimates the corrected QT among patients with antipsychotic induced tachycardia

Andric, Teodora, Winckel, Karl, Tanzer, Timothy, Hollingworth, Samantha, Isoardi, Katherine and Siskind, Dan (2021). Bazett's correction formula overestimates the corrected QT among patients with antipsychotic induced tachycardia. Schizophrenia Research, 231, 22-23. doi: 10.1016/j.schres.2021.02.022

Bazett's correction formula overestimates the corrected QT among patients with antipsychotic induced tachycardia

2021

Journal Article

Characteristics of people on long-acting injectable antipsychotics in Australia: Data from the 2010 National Survey of High Impact Psychosis

Suetani, Shuichi, Siskind, Dan, Phillipou, Andrea, Waterreus, Anna, Morgan, Vera A. and Castle, David (2021). Characteristics of people on long-acting injectable antipsychotics in Australia: Data from the 2010 National Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry, 55 (10), 958-975. doi: 10.1177/00048674211009602

Characteristics of people on long-acting injectable antipsychotics in Australia: Data from the 2010 National Survey of High Impact Psychosis

2021

Journal Article

Does switching antipsychotics ameliorate weight gain in patients with severe mental illness? A systematic review and meta-analysis

Siskind, Dan, Gallagher, Erin, Winckel, Karl, Hollingworth, Samantha, Kisely, Steve, Firth, Joseph, Correll, Christoph U. and Marteene, Wade (2021). Does switching antipsychotics ameliorate weight gain in patients with severe mental illness? A systematic review and meta-analysis. Schizophrenia Bulletin, 47 (4), 948-958. doi: 10.1093/schbul/sbaa191

Does switching antipsychotics ameliorate weight gain in patients with severe mental illness? A systematic review and meta-analysis

2021

Journal Article

Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis

Campana, Mattia, Falkai, Peter, Siskind, Dan, Hasan, Alkomiet and Wagner, Elias (2021). Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis. Schizophrenia Research, 228, 218-226. doi: 10.1016/j.schres.2020.12.002

Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis

2021

Journal Article

A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions

Tan, Madeleine S. A., Honarparvar, Faraz, Falconer, James R., Parekh, Harendra S., Pandey, Preeti and Siskind, Dan J. (2021). A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions. Psychopharmacology, 238 (3), 615-637. doi: 10.1007/s00213-020-05746-y

A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions

2021

Journal Article

Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study

Spokes, Jessica, Hollingworth, Samantha, Winckel, Karl, Kisely, Steve, Baker, Andrea, Cosgrove, Peter and Siskind, Dan (2021). Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study. Therapeutic Advances in Psychopharmacology, 11, 1-7. doi: 10.1177/20451253211000609

Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study

Funding

Current funding

  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Supervision

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au